Literature DB >> 31271337

Is type 1 tympanoplasty effective in elderly patients? Comparison of fascia and perichondrium grafts.

Serkan Cayir1, Serkan Kayabasi2, Omer Hizli3.   

Abstract

Background: Tympanoplasty is regularly performed in various ages but data about the procedure in elderly is insufficient.
Objectives: To compare the success rates and hearing outcomes of fascia and perichondrium grafts used for tympanoplasty in patients >65 years and to evaluate the prognostic factors affecting the success of tympanoplasty.
Methods: Reviewing records of 49 elderly patients underwent tympanoplasty, two groups were constituted: perichondrium (25 patients) and fascia (24 patients) groups. Ages, genders, perforation sides, type and location of perforation, graft success rates, functional success rates and air-bone gap (ABG) gains were compared.
Results: Overall graft success rate was 85.7%. After a mean follow-up of 23.3 ± 8.32 months, overall mean ABG gain was 11.33 ± 8.42 dB. Overall median postoperative ABG value (9 dB) was significantly lower compared to the median preoperative value (24 dB) (p < .001). Graft success rate was higher in perichondrium group (96%) compared to fascia group (75%) (p = .04). Functional success rate did not significantly differ between perichondrium (68%) and fascia groups (62.5%) (p = .68). Conclusion and significance: Tympanoplasty is an effective procedure with a graft success rate of 85.7% in elderly. Both fascia and perichondrium are suitable materials; however, perichondrium had higher success rate.

Entities:  

Keywords:  Elderly; fascia; perichondrium; success; tympanoplasty

Mesh:

Year:  2019        PMID: 31271337     DOI: 10.1080/00016489.2019.1633018

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  1 in total

1.  Type 1 tympanoplasty in patients with large perforations: Comparison of temporalis fascia, partial-thickness cartilage, and full-thickness cartilage.

Authors:  Caixia Xing; Hong Liu; Guodong Li; Jianfeng Li; Xin Li
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.